• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Cancers seen on US elude computer-aided detection

Article

Researchers from Seoul National University Medical Center found that ultrasound-only detected breast cancers are not very sensitive to a mammography computer-aided detection system.

Researchers from Seoul National University Medical Center found that ultrasound-only detected breast cancers are not very sensitive to a mammography computer-aided detection system.

Dr. Sang Kyu Yang and colleagues applied CAD to 96 bilateral mammograms obtained on a full-field digital system. The patient population consisted of 26 women with 29 ultrasound-detected cancers (all normal on mammography) and 70 women with 70 mammography-detected cancers. Patients in the latter group had negative findings at clinical exam.

In the ultrasound group, CAD produced 17 marks on masses and five on calcifications, correctly identifying six masses. The false-positive rate was 0.15 per image and 0.62 per case.

In the mammography group, the CAD system scored 116 marks on masses and 185 on calcifications, resulting in 58 and 139 true positives, respectively. The false-positive rate was 0.37 per image and 1.48 per case.

The sensitivity of CAD, based on radiologic primary features, was 17% for the ultrasound-detected cancers and 96% for the mammography-detected cancers. This information may be useful when applying CAD to screening mammography and adjunct ultrasound to detect early breast cancers, according to the researchers, who presented their work in a poster presentation at the 2005 RSNA meeting.

Related Videos
Improving the Quality of Breast MRI Acquisition and Processing
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Nina Kottler, MD, MS
Practical Insights on CT and MRI Neuroimaging and Reporting for Stroke Patients
Related Content
© 2024 MJH Life Sciences

All rights reserved.